Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer
Clinical trial NCT00568646 · COMPLETED
Trial details
- NCT number
- NCT00568646
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.